Literature DB >> 16417902

Myocardial proteases and matrix remodeling in inflammatory heart disease.

Susanne Rutschow1, Jun Li, Heinz-Peter Schultheiss, Matthias Pauschinger.   

Abstract

Recently, it has been demonstrated that myocardial inflammation plays a pivotal role in the development and progression of congestive heart failure. The myocardial inflammatory reaction not only affects myocardial hypertrophy and apoptosis, but it has a major influence on the regulation of extracellular matrix turnover. The balance between collagen synthesis and degradation is of crucial relevance in maintaining the structural integrity of the heart. Therefore, the overwhelming inflammatory response, as seen in acute myocarditis or inflammatory cardiomyopathy, could lead to a breakdown of this tightly regulated system. This is an additional key factor in the development and progression of heart failure. This review summarizes the importance of myocardial inflammation in respect to extracellular matrix remodeling and its possible patho-physiological role in the development and progression of left ventricular dysfunction in inflammatory heart disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417902     DOI: 10.1016/j.cardiores.2005.12.009

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

1.  Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.

Authors:  Takeki Suzuki; Ronit Katz; Nancy Swords Jenny; Neil A Zakai; Martin M LeWinter; Joshua I Barzilay; Mary Cushman
Journal:  Circ Heart Fail       Date:  2008-09-23       Impact factor: 8.790

2.  Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.

Authors:  Christine S Zuern; Britta Walker; Martina Sauter; Malte Schaub; Madhumita Chatterjee; Karin Mueller; Dominik Rath; Sebastian Vogel; Roland Tegtmeyer; Peter Seizer; Tobias Geisler; Reinhard Kandolf; Florian Lang; Karin Klingel; Meinrad Gawaz; Oliver Borst
Journal:  Clin Res Cardiol       Date:  2015-05-26       Impact factor: 5.460

3.  Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.

Authors:  Paweł Rubiś; Sylwia Wiśniowska-Śmiałek; Barbara Biernacka-Fijałkowska; Lucyna Rudnicka-Sosin; Ewa Wypasek; Artur Kozanecki; Ewa Dziewięcka; Patrycja Faltyn; Aleksandra Karabinowska; Lusine Khachatryan; Marta Hlawaty; Agata Leśniak-Sobelga; Magdalena Kostkiewicz; Wojciech Płazak; Piotr Podolec
Journal:  Heart Vessels       Date:  2016-12-21       Impact factor: 2.037

4.  Plasma levels of neutrophil gelatinase-associated lipocalin in children with heart failure.

Authors:  Mostafa S K Tawfeek; Doaa M Raafat; Khaled Saad; Naglaa K Idriss; Sherif Sayed; Doaa A Fouad; Amira A El-Houfey
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-11-30

Review 5.  Role of inflammation in the progression of heart failure.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Øie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

6.  A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro.

Authors:  Kristin M French; Archana V Boopathy; Jessica A DeQuach; Loice Chingozha; Hang Lu; Karen L Christman; Michael E Davis
Journal:  Acta Biomater       Date:  2012-07-27       Impact factor: 8.947

7.  Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

Authors:  Slava Epelman; Kevin Shrestha; Richard W Troughton; Gary S Francis; Subha Sen; Allan L Klein; W H Wilson Tang
Journal:  J Card Fail       Date:  2009-03-17       Impact factor: 5.712

8.  Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.

Authors:  Qizhu Tang; Jun Cai; Difei Shen; Zhouyan Bian; Ling Yan; You-Xin Wang; Jie Lan; Guo-Qing Zhuang; Wen-Zhan Ma; Wei Wang
Journal:  J Mol Med (Berl)       Date:  2008-12-19       Impact factor: 4.599

9.  Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass.

Authors:  Bruce H Dorman; Robert E Stroud; Michael M Wyckoff; James L Zellner; Don Botta; Amy H Leonardi; John S Ikonomidis; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2008-04       Impact factor: 3.105

Review 10.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.